Sign in Subscribe
Pharmaceutical industry

Peptide Therapeutics Market to Reach USD 51,360.30 Million by 2026

Strategic Insights

— 2 min read

The peptide therapeutics market is projected to grow at a CAGR of 9.66% over the forecast period of 2021-2026, driven by the increasing prevalence of cancers and metabolic disorders, rising investments in research and development of novel drugs, and technological advancements. The market was valued at approximately USD 28,510.60 million in 2020. North America dominates the market, and the region is expected to sustain its dominance over the coming years due to factors such as a rise in awareness levels relating to peptide therapeutics products, increasing necessity for diagnostics in cancer and other diseases, and the growing biotechnology industry.

Key Takeaways:

  • The peptide therapeutics market is expected to reach USD 51,360.30 million by 2026, growing at a CAGR of 9.66% over the forecast period of 2021-2026.
  • The market is driven by the increasing prevalence of cancers and metabolic disorders, rising investments in research and development of novel drugs, and technological advancements.
  • Cancer application is expected to register the highest CAGR over the forecast period due to the high specificity, discernment, small sizes, ease of modification, and high biocompatibility of peptides.
  • The North America region dominates the market and is expected to sustain its dominance over the coming years due to factors such as a rise in awareness levels relating to peptide therapeutics products, increasing necessity for diagnostics in cancer and other diseases, and the growing biotechnology industry.
  • The COVID-19 pandemic has disrupted the spectrum of cancer care, including delayed diagnoses, treatment, and halting clinical trials aimed at developing efficient therapeutics for cancer treatment.
  • The United States holds the largest market share in the North America region due to factors such as an increasing number of research programs in the medical industry, along with a growing number of diseases in the country.

Statistics:

  • The market was valued at approximately USD 28,510.60 million in 2020.
  • The market is expected to reach USD 51,360.30 million by 2026.
  • The market is expected to grow at a CAGR of 9.66% over the forecast period of 2021-2026.
  • An estimated 1.8 million new cancer cases were diagnosed, and 606,520 cancer deaths were reported in the United States in 2020, according to the American Cancer Society.
  • An estimated 80% of non-COVID-19 trials were stopped or interrupted as a result of the COVID-19 pandemic in the United States, according to the research article published in Applied Clinical Trials in October 2020.

Sources:

  • "Peptide Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report by ResearchAndMarkets.com
  • International Agency Research on Cancer- GLOBOCAN 2020 report
  • Nature Cancer, 2020 research article
  • Applied Clinical Trials, October 2020 research article
  • American Cancer Society estimates for 2020
  • ResearchAndMarkets.com press release
  • Businesswire.com news article

Read more